Literature DB >> 11284701

All-trans-retinal forms a visible-absorbing pigment with human rod opsin.

L I Brueggemann1, J M Sullivan.   

Abstract

Rhodopsin activation elicits transmembrane currents due to electrostatic events associated with conformational changes. We employed the sensitive rhodopsin early receptor current approach to reevaluate whether all-trans-retinal can form a visual pigment with rod opsin apoprotein. An opsin shift above 440 nm is induced in the action spectrum of charge motions caused by visible flashes in cells expressing human rod opsin and regenerated with all-trans-retinal, compared to cells without opsin. Near-ultraviolet stimulation of opsin regenerated with all-trans-retinal promotes charge motions similar to those arising from the meta-II signaling state while photochemically regenerating a pigment with ground state charge motion properties. These results indicate that all-trans-retinal can form a visual pigment with opsin, through both protonated and unprotonated Schiff base linkages and likely within the native ligand binding pocket at lysine-296. The agonist effects of all-trans-retinal may relate to its structural accommodation within the core of opsin, similar to other G-protein-coupled receptors.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11284701     DOI: 10.1021/bi002267g

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  3 in total

1.  Conformational selection and equilibrium governs the ability of retinals to bind opsin.

Authors:  Christopher T Schafer; David L Farrens
Journal:  J Biol Chem       Date:  2014-12-01       Impact factor: 5.157

2.  HEK293S cells have functional retinoid processing machinery.

Authors:  Lioubov I Brueggemann; Jack M Sullivan
Journal:  J Gen Physiol       Date:  2002-06       Impact factor: 4.086

3.  Early receptor current of wild-type and transducin knockout mice: photosensitivity and light-induced Ca2+ release.

Authors:  Michael L Woodruff; Janis Lem; Gordon L Fain
Journal:  J Physiol       Date:  2004-04-08       Impact factor: 5.182

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.